High efficiency adenovirus-mediated expression of truncated N-terminal huntingtin fragment (htt552) in primary rat astrocytes

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 4, 2009, Pages 325-334

  Wang, Linhui ^a   Lin, Fang ^a   Wu, Junchao ^a   Qin, Zhenghong ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Adenoviral vectors; Astrocytes; Huntingtin; Huntington's disease; Infection

Indexed keywords

ADENOVIRIDAE; RATTUS;

HUNTINGTIN PROTEIN, RAT; NERVE PROTEIN; NUCLEAR PROTEIN;

ADENOVIRUS; ANIMAL; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL CULTURE; CELL INCLUSION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; NEWBORN; RAT; SPRAGUE DAWLEY RAT; TIME; TRINUCLEOTIDE REPEAT; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC VECTORS; INCLUSION BODIES; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSFECTION; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 66549120577     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp021     Document Type: Article

References (30)

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72: 971-983.
2. Singhrao SK, Thomas P, Wood JD, MacMillan JC, Neal JW, Harper PS and Jones AL. Huntingtin protein colocalizes with lesions of neurodegenerative diseases: an investigation in Huntington's, Alzheimer's, and Pick's disease. Exp Neurol 1998, 150: 213-222.
3. Hebb MO, Denovan-Wright EM and Robertson HA. Expression of the Huntington's disease gene is regulated in astrocytes in the arcuate nucleu of the hypothalamus of postpartum rats. FASEB J 1999, 13:1099-1106.
4. Tobin AJ and Signer ER. Huntington's disease: the challenge for cell biologists. Trends Cell Biol 2000, 10: 531-536.
5. Myers RH, Vonsattel JP, Paskevich PA, Kiely DK, Stevens TJ, Cupples LA and Richardson EP, Jr, et al. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol 1991, 50: 729-742.
6. Li S and Li XJ. Multiple pathways contribute to the pathogenesis of Huntington disease. Mol Neurodegener 2006, 1: 19.
7. Wang LH and Qin ZH. Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies. Acta Pharmacol Sin 2006, 27: 1287-1302.
8. Petersen A, Larsen KE, Behr GG, Romero N, Przedborski S, Brundin P and Sulzer D. Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum Mol Genet 2001, 10: 1243-1254.
9. Snider BJ, Moss JL, Revilla FJ, Lee CS, Wheeler VC, Macdonald ME and Choi DW. Neocortical neurons cultured from mice with expanded CAG repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults. Neuroscience 2003, 120: 617-625.
10. Goffredo D, Rigamonti D, Tartari M, De Micheli A, Verderio C, Matteoli M and Zuccato C, et al. Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons. J Biol Chem 2002, 277: 39594-39598.
11. Saudou F, Finkbeiner S, Devys D and Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 1998, 95: 55-66.
12. Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH and Li XJ. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 2005, 171: 1001-1012.
13. Hermel E, Gafni J, Propp SS, Leavitt BR, Wellington CL, Young JE and Hackam AS, et al. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ 2004, 11: 424-438.
14. Zeron MM, Fernandes HB, Krebs C, Shehadeh J, Wellington CL, Leavitt BR and Baimbridge KG, et al. Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease. Mol Cell Neurosci 2004, 25: 469-479.
15. McCarthy KD and deVellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980, 85: 890-902.
16. Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A and Boyd MR. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res 1991, 51: 2515-2520.
17. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP and Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997, 277: 1990-1993.
18. Sieradzan KA, Mechan AO, Jones L, Wanker EE, Nukina N and Mann DM. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Exp Neurol 1999, 156: 92-99.
19. Qin ZH and Gu ZL. Huntingtin processing in pathogenesis of Huntington disease. Acta Pharmacol Sin 2004, 25: 1243-1249.
20. During MJ and Ashenden LM. Towards gene therapy for the central nervous system. Mol Med Today 1998, 11: 485-493.
21. Takuma K, Baba A and Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 2004, 72: 111-127.
22. Hebb MO, Denovan-Wright EM and Robertson HA. Expression of the Huntington's disease gene is regulated in astrocytes in the arcuate nucleu of the hypothalamus of postpartum rats. FASEB J 1999, 13: 1099-1106.
23. Chou SY, Weng JY, Lai HL, Liao F, Sun SH, Tu PH and Dickson DW, et al. Expanded polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes. J Neurosci 2008, 28: 3277-3290.
24. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK and Bromm M, et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet 1996, 13: 442-449.
25. Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R and McCutcheon K, et al. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem 1998, 273: 9158-9167.
26. Wellington CL, Singaraja R, Ellerby L, Savill J, Roy S, Leavitt B and Cattaneo E, et al. Inhibiting caspase cleavage of huntingtin reduces tox-icity and aggregate formation in neuronal and non neuronal cells. J Biol Chem 2000, 275: 19831-19838.
27. Lin F, Wu JC, Wang Y and Qin ZH. Huntingtin cleavage induced by thrombin in vitro. Acta Biochim Biophys Sin 2007, 39: 15-18.
28. Wellington CL, Ellerby LM, Gutekunst CA, Rogers D, Warby S, Graham RK and Loubser O, et al. Caspase cleavage of mutant hunting-tin precedes neurodegeneration in Huntington's disease. J Neurosci 2002, 22: 7862-7872.
29. Wu JC, Lin F and Qin ZH. Sequestration of glyceraldehyde-3-phosphate dehydrogenase to aggregates formed by mutant huntingtin. Acta Biochim Biophys Sin 2007, 39: 885-890.
30. Zala D, Benchoua A, Brouillet E, Perrin V, Gaillard MC, Zurn AD and Aebischer P, et al. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment. Neurobiol Dis 2005, 20: 785-798.